Research Archives - Canadian Alopecia Areata Foundation

OLUMIANT® Receives Health Canada Approval, Becoming the Second Approved Treatment for Severe Alopecia Areata in Canada

Eli Lilly Canada Inc. announced today that OLUMIANT (baricitinib) received regulatory approval for its severe alopecia areata indication via Notice of Compliance (NOC) from Health Canada.

canaaf2024-02-15T22:24:07+00:00January 31st, 2024|Research|

LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in Canada

This press release was posted on Pfizer's website on December 4, 2023. A dual JAK3/TEC inhibitor, LITFULO™ (ritlecitinib) is approved for adults

canaaf2023-12-05T01:04:23+00:00December 5th, 2023|Research|

A New Treatment for Severe Alopecia Areata Has Been Approved in the USA!

Learn about a new alopecia treatment in the US.

canaaf2023-06-27T19:32:09+00:00June 27th, 2023|Awareness, Clinical Trials, Research|